Print

BioNovo, Inc. (BNVI) to Present at Cowen and Company 32nd Annual Health Care Conference  
3/1/2012 10:47:04 AM

EMERYVILLE, Calif., March 1, 2012 /PRNewswire/ -- Bionovo, Inc. (OTC Link Platform: BNVI.PK), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that David Boyle, Chief Financial Officer and Senior Vice President, will be presenting at the Cowen and Company 32nd Annual Health Care Conference at 2:10 p.m. EST on March 5, 2012. The event will be held at the Boston Marriott Copley Place, in Boston, Mass.

(Logo: http://photos.prnewswire.com/prnh/20111110/SF04662LOGO)

Interested parties can access a live audio webcast of the presentation by visiting https://twst.com/pay/webcasting/cowen6/cart/show.html.

About Bionovo, Inc.
Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer; markets with significant unmet needs and billions in potential annual revenue. The Company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the OTCQB under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com.

SOURCE Bionovo, Inc.


//-->